| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AP11 Ltd | 4.9% | -10% | $4,784,762 | -$477,188 | 1,504,642 | -9.1% | AP11 Limited | 24 Jun 2025 |
| Woodline Partners LP | 4.8% | -44% | $10,299,309 | -$7,211,088 | 1,501,357 | -41% | Woodline Partners LP | 30 Sep 2025 |
| Blue Owl Capital Holdings LP | 4.3% | $3,058,156 | 1,323,877 | Blue Owl Capital Holdings LP | 31 Dec 2024 |
As of 30 Sep 2025, 72 institutional investors reported holding 12,635,689 shares of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT). This represents 40% of the company’s total 31,278,271 outstanding shares.
The largest institutional shareholders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Woodline Partners LP | 4.8% | 1,501,357 | -41% | 0.05% | $10,299,309 |
| Blue Owl Capital Holdings LP | 4.2% | 1,328,351 | 0% | 2.8% | $9,112,488 |
| VANGUARD GROUP INC | 3.8% | 1,203,231 | +4.3% | 0% | $8,254,165 |
| BAKER BROS. ADVISORS LP | 3% | 952,996 | 0% | 0.05% | $6,537,553 |
| MILLENNIUM MANAGEMENT LLC | 2.5% | 776,377 | +926% | 0% | $5,325,946 |
| HHLR ADVISORS, LTD. | 2.3% | 724,800 | 0% | 0.12% | $4,972,128 |
| Siren, L.L.C. | 2.3% | 724,771 | 0% | 0.19% | $4,971,929 |
| D. E. Shaw & Co., Inc. | 2.2% | 701,241 | +387% | 0% | $4,810,513 |
| BlackRock, Inc. | 2% | 612,717 | +27% | 0% | $4,203,239 |
| Schonfeld Strategic Advisors LLC | 1.7% | 523,774 | +462% | 0.03% | $3,593,085 |
| Affinity Asset Advisors, LLC | 1.1% | 350,000 | 0.22% | $2,401,000 | |
| READYSTATE ASSET MANAGEMENT LP | 1% | 325,359 | +21% | 0.11% | $2,231,963 |
| UBS Group AG | 0.98% | 306,766 | -46% | 0% | $2,104,415 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.96% | 299,641 | -27% | 0.04% | $2,055,537 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.91% | 283,213 | +6.7% | 0% | $1,943,670 |
| RAYMOND JAMES FINANCIAL INC | 0.89% | 278,246 | +5.1% | 0% | $1,908,768 |
| MORGAN STANLEY | 0.79% | 246,077 | +26% | 0% | $1,688,089 |
| RENAISSANCE TECHNOLOGIES LLC | 0.52% | 161,400 | +422% | 0% | $1,107,204 |
| AlphaQuest LLC | 0.37% | 117,259 | 0.05% | $804,397 | |
| FNY Investment Advisers, LLC | 0.35% | 110,650 | +28% | 0.25% | $759,000 |
| STATE STREET CORP | 0.35% | 110,488 | +11% | 0% | $757,948 |
| Qube Research & Technologies Ltd | 0.34% | 106,846 | 0% | $732,964 | |
| GSA CAPITAL PARTNERS LLP | 0.27% | 85,248 | 0.05% | $585,000 | |
| XTX Topco Ltd | 0.19% | 59,734 | +133% | 0.02% | $409,775 |
| AMERICAN CENTURY COMPANIES INC | 0.19% | 58,459 | +38% | 0% | $401,029 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 197,247 | $1,162,530 | +$193,833 | $5.92 | 7 |
| 2025 Q3 | 12,635,689 | $86,680,189 | +$6,909,221 | $6.86 | 72 |
| 2025 Q2 | 11,676,267 | $88,988,335 | +$3,493,944 | $7.62 | 67 |
| 2025 Q1 | 13,776,513 | $44,920,783 | -$15,209,264 | $3.26 | 69 |
| 2024 Q4 | 17,500,774 | $78,763,978 | -$8,862,759 | $4.50 | 66 |
| 2024 Q3 | 19,656,790 | $54,446,688 | -$7,223,512 | $2.77 | 63 |
| 2024 Q2 | 20,925,005 | $71,568,169 | -$7,440,674 | $3.42 | 80 |
| 2024 Q1 | 22,609,183 | $122,544,534 | +$43,963,572 | $5.42 | 81 |
| 2023 Q4 | 14,445,035 | $76,117,702 | -$8,913,863 | $5.42 | 51 |
| 2023 Q3 | 15,566,944 | $130,212,013 | +$129,708,727 | $8.80 | 47 |